Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8529)
All Articles published online
|
Publishing Process of This Article
|
May 18, 2015 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Narciso-Schiavon JL, Schiavon LL. Autoantibodies in chronic hepatitis C: A clinical perspective. World J Hepatol 2015; 7(8): 1074-1085 [PMID: 26052396 DOI: 10.4254/wjh.v7.i8.1074] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i8/1074.htm |
| Number | Citing Articles |
| 1 |
Marta Priora, Richard Borrelli, Simone Parisi, Maria Chiara Ditto, Cristina Realmuto, Angela Laganà, Chiara Centanaro Di Vittorio, Rosanna Degiovanni, Clara Lisa Peroni, Enrico Fusaro. Autoantibodies and Rheumatologic Manifestations in Hepatitis C Virus Infection. Biology 2021; 10(11): 1071 doi: 10.3390/biology10111071
|
| 2 |
Oleg Kurtenkov, Jelena Jakovleva, Boris Sergejev, Julia Geller. Association of the Sialylation of Antibodies Specific to the HCV E2 Envelope Glycoprotein with Hepatic Fibrosis Progression and Antiviral Therapy Efficacy. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/8881279
|
| 3 |
Bilal Olcay Peker, Aslı Gamze Şener, Firdevs Topal, Elif Sarıtaş Yüksel. The relevance between anti‐rods/rings antibody and different treatment regimens in chronic hepatitis C virus infection. Microbiology and Immunology 2021; 65(4): 171 doi: 10.1111/1348-0421.12879
|
| 4 |
Francesca Marciano, Marcella Savoia, Pietro Vajro. Celiac disease-related hepatic injury: Insights into associated conditions and underlying pathomechanisms. Digestive and Liver Disease 2016; 48(2): 112 doi: 10.1016/j.dld.2015.11.013
|
| 5 |
Amandeep Singh, Nayere Zaeri, Immanuel K. Ho. Onset of Celiac Disease after Treatment of Chronic Hepatitis C with Interferon Based Triple Therapy. Case Reports in Hepatology 2015; 2015: 1 doi: 10.1155/2015/763497
|
| 6 |
Simon H. Bridge, Sabrina Pagano, Meleri Jones, Graham R. Foster, Dermot Neely, Nicolas Vuilleumier, Margaret F. Bassendine. Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?. Hepatology International 2018; 12(1): 17 doi: 10.1007/s12072-018-9842-5
|
| 7 |
Gregor Schweighofer Zwink, Christian Pirich. The Role of Pendrin in Health and Disease. 2017; : 85 doi: 10.1007/978-3-319-43287-8_6
|
| 8 |
Camila C. Simoes, Omar A. Saldarriaga, Netanya S. Utay, Ashley E. Stueck, Sheharyar K. Merwat, Shehzad N. Merwat, Thomas D. Schiano, Maria Isabel Fiel, Heather L. Stevenson. Direct‐Acting Antiviral Treatment of Patients with Hepatitis C Resolves Serologic and Histopathologic Features of Autoimmune Hepatitis. Hepatology Communications 2019; 3(8): 1113 doi: 10.1002/hep4.1388
|
| 9 |
Geison Luiz Costa de Castro, Carlos David A. Bichara, Angélica Menezes Santiago, William Botelho de Brito, Leonn Mendes Soares Pereira, Tuane Carolina Ferreira Moura, Ednelza da Silva Graça Amoras, Mauro Sérgio Moura de Araújo, Simone Regina Souza da Silva Conde, Maria Alice Freitas Queiroz, Ricardo Ishak, Antonio Carlos Rosário Vallinoto. Polymorphisms in the TGFB1 and FOXP3 genes are associated with the presence of antinuclear antibodies in chronic hepatitis C. Heliyon 2020; 6(7): e04524 doi: 10.1016/j.heliyon.2020.e04524
|
| 10 |
Mohamed Emara, Esraa Mohsen, Riham M. Shawky, Ramadan A. El-Domany. Assessment of the Prevalence of Non-Organ-Specific Autoantibodies in Egyptian Patients with HCV. Immunological Investigations 2020; 49(6): 676 doi: 10.1080/08820139.2019.1699108
|
| 11 |
S. John Calise, Nicola Bizzaro, Thuy Nguyen, Danila Bassetti, Brunetta Porcelli, Paolo Almi, Giuseppina Barberio, Giampaola Pesce, Minoru Satoh, Edward K. L. Chan. Anti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infection. Autoimmunity Highlights 2016; 7(1) doi: 10.1007/s13317-016-0087-9
|
| 12 |
O V Moskalets. Role of infections in autoimmune disease development. Kazan medical journal 2017; 98(4): 586 doi: 10.17750/KMJ2017-586
|
| 13 |
Pooja Deshpande, Christine Bundell, Elizabeth McKinnon, Margaret Hellard, Rosemary Ffrench, Anna L. Wilkinson, Heidi Drummer, Silvana Gaudieri, Michaela Lucas. Frequent occurrence of low-level positive autoantibodies in chronic hepatitis C. Pathology 2020; 52(5): 576 doi: 10.1016/j.pathol.2020.05.001
|
| 14 |
Gianfranco LAULETTA, Sebastiano CICCO, Franco DAMMACCO. Hepatitis C virus-related autoimmunity before and after viral clearance: a single center, prospective, observational study. Minerva Medica 2024; 115(3) doi: 10.23736/S0026-4806.24.09170-5
|
| 15 |
Aref Shariati, Hamid R. Aslani, Mohammad R.H. Shayesteh, Ali Taghipour, Ahmad Nasser, Hossein Safari, Mahmood Alizade-Sani, Amin Dehghan, Taher Azimi. Are Viruses and Parasites Linked to Celiac Disease? A Question that Still has no Definite Answer. Current Pharmaceutical Biotechnology 2019; 20(14): 1181 doi: 10.2174/1389201020666190828124924
|
| 16 |
Luz Marina Navarta, Carlos Alberto Espul, Nelson Acosta‐Rivero. High prevalence of a variety of autoantibodies in a population of hepatitis C virus‐infected individuals. APMIS 2018; 126(6): 515 doi: 10.1111/apm.12850
|
| 17 |
Wolfgang Poller, Ziya Kaya, Marion Muche, Mario Kasner, Carsten Skurk, Kai Kappert, Rudolf Tauber, Felicitas Escher, Heinz-Peter Schultheiss, Hans-Jörg Epple, Ulf Landmesser. High incidence of cardiac dysfunction and response to antiviral treatment in patients with chronic hepatitis C virus infection. Clinical Research in Cardiology 2017; 106(7): 551 doi: 10.1007/s00392-017-1086-1
|
| 18 |
Wolfgang Poller, Arash Haghikia, Mario Kasner, Ziya Kaya, Udo Bavendiek, Heiner Wedemeier, Hans-Jörg Epple, Carsten Skurk, Ulf Landmesser. Cardiovascular Involvement in Chronic Hepatitis C Virus Infections – Insight from Novel Antiviral Therapies. Journal of Clinical and Translational Hepatology 2018; 6(2): 1 doi: 10.14218/JCTH.2017.00057
|
| 19 |
Endrit Shahini, Andrea Iannone, Domenico Romagno, Angelo Armandi, Sonia Carparelli, Mariabeatrice Principi, Maria Teresa Viggiani, Enzo Ierardi, Alfredo Di Leo, Michele Barone. Clinical relevance of serum non‐organ‐specific antibodies in patients with HCV infection receiving direct‐acting antiviral therapy. Alimentary Pharmacology & Therapeutics 2018; 48(10): 1138 doi: 10.1111/apt.14999
|
| 20 |
Geison Luiz Costa de Castro, Ednelza da Silva Graça Amoras, Mauro Sérgio Araújo, Simone Regina Souza da Silva Conde, Carlos David Araújo Bichara, Maria Alice Freitas Queiroz, Antonio Carlos Rosário Vallinoto. High prevalence of antinuclear antibodies in patients with chronic hepatitis C virus infection. European Journal of Medical Research 2022; 27(1) doi: 10.1186/s40001-022-00809-6
|
| 21 |
Laura López Couceiro, Elena Gómez Domínguez, Raquel Muñoz Gómez, Gregorio Castellano Tortajada, Carolina Ibarrola de Andrés, Inmaculada Fernández Vázquez. Healing of autoimmune hepatitis associated with hepatitis C virus infection treated with direct-acting antivirals. Revista Española de Enfermedades Digestivas 2018; 110 doi: 10.17235/reed.2018.5528/2018
|
| 22 |
Ciro Romano, Olga Tortorella, Liliana Dalla Mora, Dario Di Stasio, Ausilia Sellitto, Luigi Elio Adinolfi, Aldo Marrone. Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral Treatment. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.882064
|
| 23 |
Alicia Lowenstein, Hugo Fainboim, Adriana Reyes, Cynthia Lutzky, Beatriz Ameigeiras, Teresa Schroder, Maria Laura Eugenio Russmann. Autoimmune and non-autoimmune thyroid dysfunction in HCV infected and HCV–HIV co-infected patients before and after interferon alpha therapy: A prospective study. Endocrinología, Diabetes y Nutrición 2020; 67(4): 263 doi: 10.1016/j.endinu.2019.04.012
|
| 24 |
Catherine Johanet, Yannick Chantran, Eric Ballot. Auto-anticorps et pathologies hépatiques. Revue Francophone des Laboratoires 2017; 2017(490): 45 doi: 10.1016/S1773-035X(17)30078-3
|
| 25 |
Daniele Serranti, Giuseppe Indolfi, Gabriella Nebbia, Mara Cananzi, Lorenzo D’Antiga, Silvia Ricci, Stefano Stagi, Chiara Azzari, Massimo Resti. Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin. Pediatric Infectious Disease Journal 2018; 37(4): 287 doi: 10.1097/INF.0000000000001791
|
| 26 |
Alicia Lowenstein, Hugo Fainboim, Adriana Reyes, Cynthia Lutzky, Beatriz Ameigeiras, Teresa Schroder, Maria Laura Eugenio Russmann. Autoimmune and non-autoimmune thyroid dysfunction in HCV infected and HCV–HIV co-infected patients before and after interferon alpha therapy: A prospective study. Endocrinología, Diabetes y Nutrición (English ed.) 2020; 67(4): 263 doi: 10.1016/j.endien.2020.06.005
|
| 27 |
Janaína Luz Narciso-Schiavon, Leonardo Lucca Schiavon. To screen or not to screen? Celiac antibodies in liver diseases. World Journal of Gastroenterology 2017; 23(5): 776-791 doi: 10.3748/wjg.v23.i5.776
|